Ethical Issues in GBS Screening During Pregnancy
Author Information
Author(s): Michael K. Yancey, Anne Schuchat, Patrick Duff
Primary Institution: Triplet Army Medical Center, University of Florida College of Medicine, Centers for Disease Control and Prevention
Hypothesis
What are the ethical implications of routine screening and prophylaxis for Group B Streptococcus (GBS) in pregnant women?
Conclusion
The study suggests that healthcare providers have a moral obligation to discuss GBS screening and treatment options with patients, considering both maternal autonomy and the potential risks to neonates.
Supporting Evidence
- GBS infection is a major cause of neonatal morbidity and mortality.
- Most women will choose any reasonable measure to protect their infants from harm.
- Current evidence supports that the risk of acquiring neonatal infection from GBS is a continuum.
Takeaway
Doctors need to talk to pregnant women about GBS testing and treatment options, so they can make informed choices about their care.
Potential Biases
Potential bias exists in the recommendations due to varying interpretations of clinical data and patient demographics.
Limitations
The study does not provide conclusive evidence on the efficacy of prophylactic antibiotics for women without risk factors.
Participant Demographics
The study discusses pregnant women, particularly those colonized with GBS, but does not provide specific demographic data.
Want to read the original?
Access the complete publication on the publisher's website